Skip to main content
SpringerLink
Log in

Cancer Chemotherapy: New Developments and Changing Concepts

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abele, R.; Rozencweig, M.; Reich, S.D. and Lenaz, G.L.: Phase I clinical trial of carminomycin. Proceedings of AACR-ASCO 21: 329 (1980)

    Google Scholar 

  • Adamson, R.H.: Daunomycin and adriamycin: hypothesis concerning antitumor activity and cardiotoxicity. Cancer Chemotherapy Reports 58: 293–294 (1974)

    CAS  Google Scholar 

  • Billingham, M.E.; Mason, J.W.; Bristow, M.R. and Daniels, J.R.: Anthracydine cardiomyopathy measured by morphologic changes. Cancer Treatment Reports 62: 865–872 (1978)

    PubMed  CAS  Google Scholar 

  • Blum, R.M. and Carter, S.K.: Adriamycin. A new anticancer drug with significant clinical activity. Annals of Internal Medicine 80: 249–259 (1974)

    PubMed  CAS  Google Scholar 

  • Blum, R.H.; Garnick, MB.; Israel, M.; Canellos, G.P.; Henderson, I.C. and Frei, E.: Initial clinical evaluation of n-trofluorocetyl adriamycin-14-valerate(AD-32), an adriamycin analogue. Cancer Treatment Reports 63: 916–923 (1979)

    Google Scholar 

  • Blume, K.G., Beutler, E.; Bross, K.D.; Chillar, R.K.; Ellington, O.B.; Fahey, J.L.; Farbstein, M.J.; Forman, S.J.; Schmidt, G.M.; Scott, E.P.; Spruce, W.E.; Turner, M.A. and Wolf, J.L.: Bone-marrow ablation and allogenic marrow transplantation in acute leukemia. New England Journal of Medicine 302: 1041–1046 (1980)

    Article  PubMed  CAS  Google Scholar 

  • Bodey, G.D.; Freireich, E.J.; Monto, R.W. and Hewlett J.S.: Cytosine arabinoside therapy for acute leukemia in adults. Cancer Chemotherapy Reports 53: 59–66 (1969)

    CAS  Google Scholar 

  • BonFante, V.; Bonadonna, G.; Villani, F.; Di Franzo, G.; Martini, A. and Casazza, A.M.: Preliminary phase I study of 4′-epiadriamycin. Cancer Treatment Reports 63: 915–918 (1979)

    PubMed  CAS  Google Scholar 

  • Braznikova, M.G.; Zbarsky, M.K.; Kudinova, M.K.; Muravieava, L.I.; Ponomakrenko, V.l. and Potapova, N.P.: Carminomycin, a new anthracydine antibiotic. Antibiotiki (Moscow) 18: 678–681 (1973)

    Google Scholar 

  • Braznikova, M.G.; Zbarsky, V.B.; Ponomarenki, V.I. and Potapova, N.P.: Physical and chemical characteristics and structure of carminomycin. A new antitumor antibiotic. Journal Antibiotic (Tokyo), Ser. A 27: 254–259 (1974)

    Article  Google Scholar 

  • Bristow, M.R.; Billingham, M.E.; Mason, J.W. and Daniels, J.R.: Clinical spectrum of anthracydine antibiotic cardiotoxicity. Cancer Treatment Reports 62: 873–879 (1978)

    PubMed  CAS  Google Scholar 

  • Brugarolas, A.; Pachon, N. and Gonsalvez, M.: Phase I clinical study of quelamycin. Cancer Treatment Reports 62: 1527–1534 (1978)

    PubMed  CAS  Google Scholar 

  • Brugarolas, A.; Perez Lianderal, J.A.; Garcia Miralles, M.T.; Lacave, A.J.; Garcia Marco, M.; Quierdo, A.C. and Ribas, A.: Iran toxicity studies of quelamycin. Cancer Treatment Reports 63: 909–913 (1979)

    PubMed  CAS  Google Scholar 

  • Carter, S.K.: Adriamycin — A review. Journal of National Cancer Institute 55(6): 1265–1274 (1975)

    CAS  Google Scholar 

  • Carter, S.K.: Cancer treatment today and its impact on drug development with special emphasis on the phase II clinical trial. Journal of National Cancer Institute 57: 235–244 (1976)

    CAS  Google Scholar 

  • Carter, S.K.: Cancer chemotherapy as it approaches middle age. Cancer Chemotherapy and Pharmacology 1: 1–3 (1977)

    Google Scholar 

  • Carter, S.K.. The clinical evaluation of analogues I — the overall problem. Cancer Chemotherapy and Pharmacology 1: 69–72 (1978)

    PubMed  CAS  Google Scholar 

  • Carter, S.K.; Schabel, F.M., Jr.; Broder, L.E. and Johnston, T.P.: l,3-Bis(2-chloroethyl)-l nitrosourea (BCNU) and other nitrosoureas in cancer treatment: a review. Advances in Cancer Research 16: 273–332 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Carter, S.K.; Bakowski, M. and Hellmann, K.: Chemotherapy of Cancer (Wiley Press, New York 1977)

    Google Scholar 

  • Champlin, R.; Sarna, G.; Stitzel, K.; Wilson, F. and Gale, R.P.: High dose mitomycin with autologous bone marrow rescue, a phase I study in the dog and in man. Proceedings of AACR-ASCO 21: 353(1980)

    Google Scholar 

  • Cheng, C.C.; Zbinden, G. and Zee-Cheng Riley: Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracydine antibiotics. Journal of Pharmaceutical Sciences 68: 393–396 (1979)

    Article  PubMed  CAS  Google Scholar 

  • Comis, R.J.; Ginsberg, S. and Crooke, S.J.: A phase I study of carminomycin administered by intravenous bolus every 4 weeks. Proceedings of AACR-ASCO 21: 333 (1980)

    Google Scholar 

  • Cortes-Funes, H.; Gonsalvez, M.; Moyano, A. and Manas, A.: Cancer Treatment Reports 63: 903–908 (1979)

    PubMed  CAS  Google Scholar 

  • Deprez-de Compeneere, D.; Baurain, R. and Trouet, A.: Pharmacokinetics, toxicologic and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin. Cancer Treatment Reports 68: 861–867 (1979)

    Google Scholar 

  • Dudnik, Y.V.; Ostanina, L.N.; Kozyman, L.I.; and Gause, G.G.: Action mechanism of carminomycin. Antibiotiki (Moscow) 19: 514–517 (1974)

    CAS  Google Scholar 

  • Ellison, R.R.; Holland, J.F.; Weil, M., Jacquillat, C; Boiron, M.; Bernard, J.; Sawitsky, A.; Rosner, F.; Gussof, B.; Silver, R.T.; Karanas, A.; Cuttner, J.; Spurr, C.L.; Hayes, D.M.; Blom, J.; Leone, L.A.; Haurani, F.; Kyle, R.; Hutchison, J.L.; Forcier, R.J. and Moon, J.H.: Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 32: 507–523 (1968)

    PubMed  CAS  Google Scholar 

  • Gale, R.P.G.: Autologous bone marrow transplantation in patients with cancer. Journal of the American Medical Association 243: 540–543 (1980)

    Article  PubMed  CAS  Google Scholar 

  • Goldsmith, M.A.; Slavik, M. and Carter, S.K.: Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Research 35: 1354–1364 (1975)

    PubMed  CAS  Google Scholar 

  • Gonsalvez, M.; Blanco, M.F. and Vivero, C: Quelamycin a new derivative of adriamycin with several possible therapeutic advantages. European Journal of Cancer 14: 1185–1190 (1978)

    Article  Google Scholar 

  • Gonsalvez, M.; VonRossum, G.D.V. and Blanco, M.F.: Inhibition of sodium-potassium activated adenosine. 5′-triphosphate and ion transport by adriamycin. Cancer Research 39: 257–261 (1979)

    Google Scholar 

  • Hamburger, A. and Salmon, S.-. Primary bioassay of human tumor stem cells. Science 197: 461–464 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Hamburger, A.; Salmon, S.; Kim, M.; Trent, J.; Soehulen, B.; Alberts, D. and Schmidt, H.: Direct cloning of human ovarian carcinoma cells in agar. Cancer Research 38: 3438–3444 (1978)

    PubMed  CAS  Google Scholar 

  • Harrap, K.R.: M-AMSA. Cancer Topics 2 (No. 12): 2–3 (1980)

  • Hayes, F.A.; Green, A.A. and Mauer, A.M.: Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Research 37: 3766–3770 (1977)

    PubMed  CAS  Google Scholar 

  • Israel, M.; Modest, E.J. and Frei, E.: N-trifluoroacetyl-adriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Cancer Research 35: 1365–1368 (1975)

    PubMed  CAS  Google Scholar 

  • Jacquillat, C; Auclerc, M.F.; Weil, M.; Maral, J.; Degos, L.; Auclerc, G.; Tobelem, G.; Schaisan, G. and Bernard, J.: Clinical activity of detorubicin: a new anthracycline derivative. Cancer Treatment Reports 68: 889–893 (1979)

    Google Scholar 

  • Krishan, A.; Israel, M. and Modest, E.J.: Differences in cellular uptake and cytofluorescence of adriamycin and n-trifluoro-acetyladriamycin-14-valerate. Cancer Research 36: 2114–2116 (1976a)

    Google Scholar 

  • Krishan, A.; Pitman, S.W.; Tattersall, M.H.N.; Paika, K.D.; Smith, D.C. and Frei, E., Ill: Flow microfluorimetric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. Cancer Research 36: 3813–3820 (1976b)

    PubMed  CAS  Google Scholar 

  • Legha, S.S.: Phase 1 clinical investigation of 4′-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. Cancer Research 38: 3712–3716(1978)

    PubMed  CAS  Google Scholar 

  • Litamid, J.; Spitzer, G.; Valdivieso, M. and Verma, A.: High dose combination chemotherapy followed by autologous bone marrow transplantation in limited oat cell carcinoma of the lung. Proceedings of AACR-ASCO 21: 452 (1980)

    Google Scholar 

  • Lyman, G.H.; Williams, C.C. and Preston, D.: The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. New England Journal of Medicine 302: 257–260 (1980)

    Article  PubMed  CAS  Google Scholar 

  • Maral, R.; Ducep, J.B. and Farge, D.: Preparation et activité antitumorale expérimentale d’un nouvel antibiotique semisynthetique: la diethoxyacetoxy-14-daunorubicine (33921 R.P) C.R. Acad Sciparis 286: 443–446 (1978)

    CAS  Google Scholar 

  • Mason, J.W.; Bristow, M.R.; Billingham, M.E. and Daniels, J.R.: Invasive and noninvasive methods of assessing adriamycin cardiotoxic effect in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treatment Reports 62: 857–864 (1978)

    PubMed  CAS  Google Scholar 

  • Merski, J.A.; Daskal, Y.; Crooke, ST. and Busch, H.: Acute ultrastructural effects of the antitumor antibiotic carminomycin on nucleoli of rat tissues. Cancer Research 39: 1239–1244 (1979)

    PubMed  CAS  Google Scholar 

  • Oconnel, R.A.: Leucocytosis during lithium carbonate treatment. International Pharmacology and Experimental Therapy 4: 30–34 (1970)

    Google Scholar 

  • Parker, L.M.; Hirst, M. and Israel, M.: N-trifluoroacetyl adriamycin-14-valerate: additional mouse antitumor and toxicity studies. Cancer Treatment Reports 62: 119–127 (1978)

    PubMed  CAS  Google Scholar 

  • Perevodchikova, N.I.; Gorbunova, V.A.; Lichinitser, M.R.; Borisov, V.l.; Alekseyev, N.A. and Vygovskaya, Y.I.: First phase of a clinical study of the antitumor antibiotic carminomycin. Antibiotiki (Moscow) 20: 853–856 (1975)

    Google Scholar 

  • Perevodchikova, N.I.; Lichinitser, M.A. and Gorbunova, V.A.: Phase I clinical study of carminomycin: its activity against soft tissue sarcomas. Cancer Treatment Reports 61: 1705–1707 (1977)

    PubMed  CAS  Google Scholar 

  • Phillips, G.L.; Fay, J.W.; Wolff, S.N.; Karanes, C; Herzig, R.H. and Herzig, G.P.: Intensive BCNU and autologous bone marrow transplantation for refractory malignancy. A phase I study. Proceedings of AACR-ASCO 21: 180 (1980)

    Google Scholar 

  • Radomski, J.L.; Fuyat, H.N.; Nelson, A.A. and Smith, P.K.: The toxic effects, excretion and distribution of lithium chloride. Journal of Pharmacology and Experimental Therapeutics 100: 429–444 (1950)

    PubMed  CAS  Google Scholar 

  • Rothstein, G.; Clarkson, D.R.; Larsen, W.; Grossen, B.I. and Athens, J.W.: Effect of lithium on neuthrophil mass and production. New England Journal of Medicine 298: 178–180 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Salmon, S.E.; Hamburger, A.W.; Soehnlen, B.; Durie, B.G.M., Alberts, D.S. and Moon, T.E.: Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. New England Journal of Medicine 298: 1321–1328 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Salmon, S.; Soehnlen, B.; Durie, B.; Alberts, D.; Meyskens, F.; Chen, H. and Moon, T.: Clinical correlations of drug sensitivity in tumor stem cell assay. Proceedings of AACR-ASCO 20: 340(1979)

    Google Scholar 

  • Selawry, O.S. and Hansen, H.H.: Superiority of CCNU[l-(2-chloroethy)-3-cyclohexyl-1-nitrosourea; NSC 79037] over BCNU (l,3-bis(2-chloroethyl)-l-nitrosourea; NSC 409962] in treatment of advanced Hodgkin’s disease. Proceedings of the American Association for Cancer Research 13: 46 (1972)

    Google Scholar 

  • Sieber, S.M. and Adamson, R.H.: Toxicity of antineoplastic agents in man. Chromosomal, aberrations, effects, congenital malformations and carcinogenic potential. Advances in Cancer Research 22: 57–155(1975)

    Article  PubMed  CAS  Google Scholar 

  • Straus, M.J.: Combination chemotherapy in advanced lung cancer with increased survival. Cancer 38: 2232–2241 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Takvorian, T.; Parker, L.M.; Hocbers, F.H.; Zervas, N.P.; Frei, E. and Canellos, G.P.: Single high doses of BCNU with autologous bone marrow: A phase I study. Proceedings of AACR-ASCO 21: 341 (1980)

    Google Scholar 

  • Tannock, I.: Cell kinetic and chemotherapy: a critical review. Cancer Treatment Reports 62: 1117–1133 (1978)

    PubMed  CAS  Google Scholar 

  • Thomas, E.D.; Buckner, CD.; Clift, R.A.; Fefer, A.; Johnson, F.L.; Neiman, P.E.; Sale, G.E.; Sanders, J.E.; Singer, J.W.; Shulman, H.; Storb, R. and Weiden, P.L.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New England Journal of Medicine 301: 597–599 (1979)

    Article  PubMed  CAS  Google Scholar 

  • Thomas, E.D.; Storb, R. and Clift, R.A.: Bone marrow transplantation. New England Journal of Medicine 292: 832–843 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Van Echo, DA.: Phase 1 clinical and pharmacological study of 4′-(9-aeridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule. Cancer Research 39: 3881 (1979)

    PubMed  Google Scholar 

  • Von Hoff, D.D.: Phase I study of meihanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(M-AMSA) using a single-dose schedule. Cancer Treatment Reports 62: 1421 (1978)

    Google Scholar 

  • Von Hoff, D.: In Salmon (Ed) Proceedings of the Human Tumor Colony Conference (Alan Liss, New York 1979)

    Google Scholar 

  • Von Hoff, D. and Johnson, G.: Secretion of tumor markers in the human tumor stem cell system. Proceedings of AACR-ASCO 20: 51 (1979)

    Google Scholar 

  • Von Hoff, D.; Johnson, G. and Glaubiger, D.: Initial experience with the human tumor stem cell assay system: potential and problems. Submitted for publication, (1979a)

  • Von Hoff, D.D.; Layard, D.D. and Basa, P.: Risk factors for adriamycin-induced congestive heart failure (In press, 1979b)

  • Von Hoff, D.; Pollard, E.; Kuhn, J.; Murray, E. and Coltman, C.A.: Phase I clinical investigation of DHAD(NSC 301739), a new anthracenedione. Cancer Research 40: 1516–1518 (1980)

    Google Scholar 

  • Wasserman, T.H.; Slavik, M. and Carter, S.K.: Clinical comparison of the nitrosoureas. Cancer 36: 1258–1268 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Young, D.M.; Ward, J.M. and Pelham, J.F.: Quelamycin-induced cardiotoxicity in rabbits and rats. Proceedings of AACR-ASCO 19: 56 (1978)

    Google Scholar 

  • Zander, A.R.; Verma, D.S.; Spitzer, G.; Culbert, S.; Peters, L.; Moredic, K. and Dickie, K.A.: Autologous bone marrow transplantation in acute leukemia. International Journal of Radiation, Oncology, Biology and Physics 5: 1709–1710 (1979)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, Palo Alto, California, 94304, USA

    Stephen K. Carter (Director)

Authors
  1. Stephen K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carter, S.K. Cancer Chemotherapy: New Developments and Changing Concepts. Drugs 20, 375–397 (1980). https://doi.org/10.2165/00003495-198020050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198020050-00003

Keywords

Search

Navigation